⚠ RecallRadar📷 ScanGuidesRecentOfficial U.S. recall notices, restated plainly

Medtronic MiniMed, Inc.: CareLink Clinic, REF: MMT-7350

Medical DevicesSource: FDA (device) · Date: 2026-10-28

Recall status
Ongoing (still active)
Severity
Class II: could cause temporary or reversible health problems What recall classes mean
Where sold
US Nationwide distribution in the state of KS.

Common questions

Is Medtronic MiniMed CareLink Clinic REF: MMT-7350 recalled?
Yes. FDA (device) recalled Medtronic MiniMed CareLink Clinic REF: MMT-7350 on 2026-10-28. Recall status: Ongoing (still active).
What is the hazard?
CareLink Clinic software version 4.4A includes a software defect in the Settings Calculator feature in which the calculation logic fails to use custom values entered by healthcare professionals (HCPs) for Total Daily Dose (TDD) or Long-acting insulin when calculating the Carb Ratio, Insulin Sensitivity Factor (ISF)...
Where was it sold?
US Nationwide distribution in the state of KS.

Read the official notice at FDA (device) →

Share on XFacebookRedditEmail

Is Medtronic MiniMed recalled?

Guides: Which agency handles which recall (FDA vs USDA vs CPSC vs NHTSA)

More recalls

The text below is copied from the official FDA (device) record. If anything differs, the official notice is correct.

Company / brand
Medtronic MiniMed, Inc.
Product
CareLink Clinic, REF: MMT-7350
Reason / hazard
CareLink Clinic software version 4.4A includes a software defect in the Settings Calculator feature in which the calculation logic fails to use custom values entered by healthcare professionals (HCPs) for Total Daily Dose (TDD) or Long-acting insulin when calculating the Carb Ratio, Insulin Sensitivity Factor (ISF), and Max Recommended value for Rapid-acting insulin. Instead, the calculator continues to use the system-recommended values, resulting in incorrect rapid-acting insulin parameters. If an HCP or patient inputs these incorrect setting values into the patient's MiniMed Go app, the patient could deliver higher or lower insulin doses compared to their insulin needs, potentially leading to over/under delivery of insulin with a severity ranging from Catastrophic (death from severe hypoglycemia) to Minor (self-treatable hypoglycemia/hyperglycemia).
What to do (remedy)

How to claim your remedy

Classification
Class II
Status
Ongoing
Distribution / sold at
US Nationwide distribution in the state of KS.
Recall initiated
2026-09-11
Code info
UDI-DI: 0763000B00008748K. Software Versions: 4.4A Software Available: US: Between June 4th, 2026, and June 8th, 2026.
Product quantity
1
Voluntary mandated
Voluntary: Firm initiated
City
Northridge
State
CA
Country
United States
Event id
99765
Free daily digest + "My products" watchlist

Get the daily digest, and tell us what to watch. Everything is optional except your email.

Free allergen alerts:

Categories:

Privacy: we store only what you enter here, use it only to send recall alerts you asked for, never sell or share it, and you can unsubscribe anytime. Double opt-in: we will email you a confirmation link before sending anything; alerts start only after you confirm. Every email has unsubscribe and manage-watchlist links.